CytomX Therapeutics, Inc. (CTMX) Operating cash flow 2016–2025
CytomX Therapeutics, Inc. (CTMX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$75.6MFY2025 · since FY2016: -$2.0M → -$75.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$75.6M | +12.3% |
| FY2024 | -$86.2M | -53.9% |
| FY2023 | -$56.0M | +49.4% |
| FY2022 | -$110.8M | +6.9% |
| FY2021 | -$119.0M | -2363.4% |
| FY2020 | $5.3M | +103.7% |
| FY2019 | -$140.5M | -86.0% |
| FY2018 | -$75.5M | -144.3% |
| FY2017 | $170.4M | +8484.5% |
| FY2016 | -$2.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice